StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care operating margin

Operating margin is operating income as a percentage of revenue.

Tandem Diabetes Care's operating margin for the twelve months ending Jun 30, 2026 was -4.4%. For fiscal 2025 it was -18.5%, against -10.5% the year before. The highest annual figure on record is 3.2% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-18.5%−7.9
FY2024Dec 31, 2024-10.5%+20.6
FY2023Dec 31, 2023-31.2%−19.6
FY2022Dec 31, 2022-11.6%−14.8
FY2021Dec 31, 20213.2%+4.8
FY2020Dec 31, 2020-1.6%+3.0
FY2019Dec 31, 2019-4.6%+19.7
FY2018Dec 31, 2018-24.3%+34.2
FY2017Dec 31, 2017-58.5%+34.1
FY2016Dec 31, 2016-92.6%+2.1
FY2015Dec 31, 2015-94.7%+57.5
FY2014Dec 31, 2014-152.2%+18.2
FY2013Dec 31, 2013-170.4%+1164.9
FY2012Dec 31, 2012-1335.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-5.4%+16.1
Q1 FY2026Mar 31, 2026-7.1%+44.5
Q4 FY2025Dec 31, 20252.9%+3.1
Q3 FY2025Sep 30, 2025-9.2%+1.5
Q2 FY2025Jun 30, 2025-21.5%−7.7
Q1 FY2025Mar 31, 2025-51.6%−29.8
Q4 FY2024Dec 31, 2024-0.2%+17.6
Q3 FY2024Sep 30, 2024-10.7%+6.3
Q2 FY2024Jun 30, 2024-13.9%+5.9
Q1 FY2024Mar 31, 2024-21.7%+53.7
Q4 FY2023Dec 31, 2023-17.8%−9.8
Q3 FY2023Sep 30, 2023-17.0%+6.2
Q2 FY2023Jun 30, 2023-19.8%−13.7
Q1 FY2023Mar 31, 2023-75.5%−66.7
Q4 FY2022Dec 31, 2022-8.1%−14.1
Q3 FY2022Sep 30, 2022-23.2%−27.5
Q2 FY2022Jun 30, 2022-6.1%−9.3
Q1 FY2022Mar 31, 2022-8.7%−6.4
Q4 FY2021Dec 31, 20216.1%−5.0
Q3 FY2021Sep 30, 20214.3%+5.1
Q2 FY2021Jun 30, 20213.2%+14.2
Q1 FY2021Mar 31, 2021-2.3%+11.6
Q4 FY2020Dec 31, 202011.1%+9.1
Q3 FY2020Sep 30, 2020-0.8%+5.5
Q2 FY2020Jun 30, 2020-11.0%−9.0
Q1 FY2020Mar 31, 2020-13.9%+2.8
Q4 FY2019Dec 31, 20192.0%+1.2
Q3 FY2019Sep 30, 2019-6.3%+27.6
Q2 FY2019Jun 30, 2019-2.0%+39.0
Q1 FY2019Mar 31, 2019-16.7%+40.1
Q4 FY2018Dec 31, 20180.7%+24.5
Q3 FY2018Sep 30, 2018-34.0%+14.8
Q2 FY2018Jun 30, 2018-41.0%+47.9
Q1 FY2018Mar 31, 2018-56.8%+55.1
Q4 FY2017Dec 31, 2017-23.8%+22.4
Q3 FY2017Sep 30, 2017-48.8%+182.4
Q2 FY2017Jun 30, 2017-88.9%–
Q1 FY2017Mar 31, 2017-111.9%–
Q4 FY2016Dec 31, 2016-46.2%–
Q3 FY2016Sep 30, 2016-231.1%–

More Tandem Diabetes Care figures

See a number that looks wrong?